Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             266 results found
no title author magazine year volume issue page(s) type
1 Abemaciclib for treating patients with HR+, HER2- advanced/metastatic breast cancer in Spain: a real-world study Blancas, I.

175 S1 p. S59-S60
article
2 Accelerated partial breast irradiation (APBI) in a single 18 Gy fraction with high-dose-rate brachytherapy (HDR) Anchuelo, J.

175 S1 p. S49-S50
article
3 Accelerated Partial Breast Irradiation With Multicatheter Brachytherapy after second conservative-surgery Martinez Montesinos, I.

175 S1 p. S47-S48
article
4 Accuracy of pre-operative axillary US and biopsy in breast cancer patients Hudson-Phillips, S.

175 S1 p. S29
article
5 A comparative analysis between vertical rectus abdominis myocutaneous (VRAM) flap and transverse rectus abdominis myocutaneous (TRAM) flap as options for post-mastectomy chest wall reconstruction Bhattacharya, A.

175 S1 p. S21
article
6 A composite prognostic model for overall survival (OS) based on residual cancer burden (RCB) and tumor-infiltrating lymphocytes (TILs) on residual disease (RCB+TIL) in HER2+ breast cancer patients treated with neoadjuvant therapy: a multicenter study Miglietta, F.

175 S1 p. S3
article
7 Advanced breast cancer journey: a consensus guidance from a multidisciplinary panel for improving clinical practice in Portugal Pinto, L.

175 S1 p. S70
article
8 Advanced breast cancer treatment after CDK4/6– inhibitors - the experience of a Hospital Center Costa, M.

175 S1 p. S70-S71
article
9 Agreement on risk assessment and chemotherapy recommendations among breast cancer specialists: a survey within the MINDACT cohort Lopes Cardozo, J.

175 S1 p. S64
article
10 A higher number of HSP70 positive immune cells in a deep layer of TNBC is associated with a higher FOXP3 expression and a higher risk of axillary lymph node involvement Car Peterko, A.

175 S1 p. S80
article
11 AI-based smartphone App using a single-lead ECG for automated QTc diagnostics in oncology Tonk, C.H.

175 S1 p. S71
article
12 Alternative breast cancer localisation techniques in Wales: an early experience Warren, A.

175 S1 p. S16
article
13 A machine learning (ML) approach for identifying genetic biomarkers and new targets associated with impaired survival of breast cancer patients Sanz Martin, G.

175 S1 p. S82
article
14 A multicenter cohort of breast cancer patients with long-term 125I targeted axillary dissection Munck, F.

175 S1 p. S14-S15
article
15 A multimodal approach for the management of co-morbid cardiotoxicity in the elderly breast cancer patients Karanasiou, G.

175 S1 p. S40
article
16 Analysis of factors with impact on duration of hospitalisation for patients operated for breast cancer during COVID 19 pandemic Maksimovic, Z.

175 S1 p. S15-S16
article
17 Analysis of fatty acid composition profile of tumoral and non-tumoral tissues from breast cancer patients Gonzalez Yebra, B.

175 S1 p. S84-S85
article
18 Analysis of rare disruptive germline mutations in 2135 enriched BRCA-negative breast cancer cases excludes additional high-impact susceptibility genes Loveday, C.

175 S1 p. S39
article
19 An expanded 29-gene HER2 signature robustly identifies genomic HER2-Type early-stage breast tumors Ellappalayam, A.

175 S1 p. S78-S79
article
20 An individualized breast cancer risk assessment model for women attending screening in BreastScreen Norway Louro, J.

175 S1 p. S8-S9
article
21 A novel biomarker to predict DNA-Repair-inhibitor response in stage I-III high risk breast cancer patients Barcaru, A.

175 S1 p. S79
article
22 Anthracycline versus no anthracycline neoadjuvant therapy for HER2 breast cancer: real world evidence Soares De Pinho, I.

175 S1 p. S62
article
23 Anxiety and depression screening during neoadjuvant chemotherapy treatment in early breast cancer patients: a multicenter longitudinal observational study Rodrigues, J.

175 S1 p. S36
article
24 A Phase III, Randomized, Multicenter, Double-blind Study to Compare Efficacy and Safety of EG12014 (EirGenix Trastuzumab) with Herceptin® as Neoadjuvant Treatment in Combination with Anthracycline/Paclitaxel-based Systemic Therapy in Patients with HER2-positive Early Breast Cancer Henneberg, J.

175 S1 p. S60
article
25 A retrospective evaluation of factors associated with upstage to malignancy for breast lesions of uncertain malignant potential (B3): findings from an American cohort Casaubon, J.

175 S1 p. S95-S96
article
26 Assessing the application of multidisciplinary management of locally advanced breast cancer in Egyptian female patients at Alexandria surgical oncology unit AbouElnagah, G.

175 S1 p. S70
article
27 Assessment and management of lesions of uncertain malignant potential of the breast at Trieste Breast Unit: a single center experience Scomersi, S.

175 S1 p. S89
article
28 Association between physical activity and subsequent cardiovascular disease among 5-year breast cancer survivors Kim, K.H.

175 S1 p. S41
article
29 A study of the anti-proliferative and anti-migration effects of polyphenol compounds in Maltese extra virgin olive oil on different breast cancer cell lines Tovar Parra, J.D.

175 S1 p. S76
article
30 A systematic review on management of breast cancer patients during the covid 19 pandemic: To assess if there was a clinical delay in treatment and patient perception on delayed treatment. Literature review of the current covid 19 management guidelines for breast cancer patients Shah, R.N.

175 S1 p. S65
article
31 Author Index
175 S1 p. S97-S108
article
32 Axillary Nodal Management in the setting of Neoadjuvant Chemotherapy Pérez Cartón, S.

175 S1 p. S66
article
33 Bacterial β-glucuronidase activity in postmenopausal breast cancer patients: a pilot study Hillege, L.

175 S1 p. S84
article
34 Behavior of locally advanced invasive lobular carcinoma according to primary treatment Sanchez Mateos Enrique, M.R.

175 S1 p. S67
article
35 Black seed oil supplement had positive effects on blood concentration and mRNA expression levels of estrogen and SHBG in premenopausal women with overweight and obesity: a crossover, double blind, placebo controlled randomized clinical trial Razmpoosh, E.

175 S1 p. S42
article
36 Borderline and malignant phyllodes tumors of the breast: a population-based study of all cases in the Netherlands 1989–2020 Bartels, S.

175 S1 p. S4
article
37 Borderline phyllodes tumors do not require wide resection margin Yoon, K.

175 S1 p. S21-S22
article
38 Breast cancer after In Vitro Fecundation: Ovary response and prognostic factors Izquierdo, M.

175 S1 p. S61
article
39 Breast cancer and pregnancy: about a series of cases and review of the literature Bannour, B.

175 S1 p. S75
article
40 Breast cancer axillary dissection a “lost procedure, sometimes still necessary…” how to prevent the lost of a surgical technique using cadaver body and Simlife Bau’, M.G.

175 S1 p. S12-S13
article
41 Breast cancer in elderly patients in a Venezuelan breast center. How we manage the axilla Acosta-Marin, V.

175 S1 p. S19-S20
article
42 Breast cancer management with CDK4/6 inhibitors as first line treatment: a single institution retrospective review Villa, F.

175 S1 p. S69-S70
article
43 Breast cancer nutritional risk factors: insights from the Tesco 1.0 dataset Yilmaz, D.

175 S1 p. S42-S43
article
44 Breast Cancer Whole Blood Screening: Analytical and Clinical Performance from Early Analysis of the International Identify Breast Cancer (IDBC) Study Bundred, N.

175 S1 p. S8
article
45 Budget impact model for magnetic tracers in the detection of sentinel lymph nodes for operable breast cancer Belaroussi, I.

175 S1 p. S23
article
46 Capsaicin patch 179 mg (CP) for the management of localized neuropathic pain (LNP) after breast cancer (BC) treatment Anchuelo, J.

175 S1 p. S57
article
47 Causes and consequences of delayed diagnosis in breast cancer screening; focus on mammographic features and tumour characteristics Van Der Veer, E.

175 S1 p. S30
article
48 Caveolin-1 haplotypes as predictor for locoregional recurrence in breast cancer Godina, C.

175 S1 p. S85
article
49 Cell-free DNA concentration in patients with different molecular subtypes of breast cancer Karathanasis, P.

175 S1 p. S83
article
50 Change in Shoulder range of motion, strength and the disabilities of the arm, shoulder, and hand (DASH) within 6 months after breast cancer surgery: A Prospective Observational Study Ryu, J.

175 S1 p. S10-S11
article
51 Characteristics of patients with metastatic luminal breast cancer (MLBC) and ESR1 polymorphism Tarasenko, T.

175 S1 p. S71
article
52 Circulating microRNAs for early detection of therapy-related cardiac events in HER2-positive breast cancer patients: an explorative analysis from NeoALTTO Pizzamiglio, S.

175 S1 p. S77-S78
article
53 Clinical and Experimental investigation of AKT1/2/3 isoforms indicated non-redundant isoform specific role in driving stemness and Cisplatin resistance in TNBCs Malik, F.

175 S1 p. S86
article
54 Clinical and sociodemographic determinants of disease-specific health-related quality of life in long-term breast cancer survivors Doege, D.

175 S1 p. S55
article
55 Clinical benefit and tolerability of CDK4/6 inhibitors in the treatment of breast cancer advanced in the geriatric population – real life data from a Hospital Center Costa, M.

175 S1 p. S63
article
56 Clinicopathologic Risk Factors of Brain Metastasis in Breast Cancer Patients: A Systematic Review and Meta-analysis Garcia, K.B.

175 S1 p. S94
article
57 Co-expressing genes with TACSTD2 and interacting microRNAs in patients with recurrent luminal breast cancers Kok, V.C.

175 S1 p. S76
article
58 Comparison of ER, PR, HER2 and Ki67 expression by MammaTyper® RT-qPCR and immunohistochemistry (IHC) on needle core biopsies of breast cancer Shaaban, A.

175 S1 p. S87-S88
article
59 Comparison of Technetium (Tc)- and SPIO-guided Sentinel Lymph Node Biopsy (SLNB) in Patients with Neoadjuvant Chemotherapy in Early Breast Cancer – first retrospective data Munawwar, B.

175 S1 p. S14
article
60 Complete response of ductal carcinoma in situ to neoadjuvant systemic therapy in HER2-positive invasive breast cancer patients: a nationwide analysis Ploumen, R.

175 S1 p. S1
article
61 Comprehensive mutation profiling of PIK3CA gene in Indian breast cancer patients Kumar, R.

175 S1 p. S33
article
62 Concordance between manual pathologist scoring and an Artificial Intelligence Deep Learning-based algorithm for Ki-67 immunohistochemical scoring in breast cancer Badr, N.M.

175 S1 p. S59
article
63 Contents
175 S1 p. iv-v
article
64 Contrast Enhanced Mammography in Breast Cancer Surveillance Elder, K.

175 S1 p. S8
article
65 Contrast enhanced mammography in further assessment of screen-detected breast cancer Maccallum, C.

175 S1 p. S33-S34
article
66 Contribution and performance of subsidized mammography and breast cancer detection rate in underserved populations of rural and urban areas of Sindh, Pakistan Shamsi, U.

175 S1 p. S44-S45
article
67 Cost-effectiveness of abemaciclib in early breast cancer patients: one size fits all or tailoring to patients’ needs Jongbloed, L.

175 S1 p. S60-S61
article
68 Cost-effectiveness of first-line ribociclib use vs palbociclib in the treatment of postmenopausal women with HR+/HER2− advanced breast cancer: analysis based on final OS results of MONALEESA-2 and PALOMA-2 Cameron, D.A.

175 S1 p. S67
article
69 Coverage and Socio-economic inequalities in breast cancer screening in Low- and Middle-Income Countries: Analysis of Demographic and Health Surveys between 2010 and 2019 Abila, D.B.

175 S1 p. S45
article
70 COVID-19, breast cancer care, and social determinants of health: a cross-sectional study to investigate the impact of a pandemic on health and health care Myers, C.

175 S1 p. S75
article
71 Cumulative risks of false positive recall and screen detected breast cancer after multiple rounds of screening Kregting, L.

175 S1 p. S44
article
72 Cytokine identification in seroma fluid after mastectomy in breast cancer patients – first results of SerMa pilot study subgroup Ditsch, N.

175 S1 p. S86
article
73 Depression, anxiety and stress among women with breast cancer in Sri Lanka Seneviratne, S.

175 S1 p. S55
article
74 Depression, anxiety and the risk of breast cancer among premenopausal and postmenopausal women: an individual participant data meta-analysis Basten, M.

175 S1 p. S95
article
75 Depression, loneliness and apathy in older breast cancer survivors: five-year follow-up from the Climb Every Mountain study Lemij, A.

175 S1 p. S53
article
76 Designing digital health tools for helping metastatic breast cancer patients manage symptoms at home and optimize quality of life: PRICE and MET-GUIDE Kassianos, A.

175 S1 p. S35
article
77 Detecting actionable PIK3CA mutations through next-generation sequencing (NGS) in hormone receptor positive (HR+)/HER2-negative advanced/metastatic breast cancer (MBC): a real-life experience Caldart, A.

175 S1 p. S38-S39
article
78 Developing an effective self-management web-based intervention using co-designed patient and multidisciplinary research: ePainQ Hartup, S.

175 S1 p. S56
article
79 Development and Validation of a Digital-Artificial Intelligent (AI) enabled Assay to predict early-stage breast cancer recurrence Fernandez, G.

175 S1 p. S85
article
80 Development of a multiplex dPCR assay for ERBB2 amplification in breast cancer Meng, P.

175 S1 p. S80
article
81 Development of antibody-drug conjugates targeting the CDCP1 receptor for the treatment of Triple negative and metastatic breast cancer Gough, M.

175 S1 p. S81-S82
article
82 Digital health applications to support patients with breast cancer: Effects of two tailored, dialogue-based programs on quality of life Holtdirk, F.

175 S1 p. S56-S57
article
83 Does fertility preservation affect the onset of the oncological treatment and the response to neoadjuvant chemotherapy in breast cancer? Baulies, S.

175 S1 p. S40-S41
article
84 Does preservation of intercostobrachial nerve during axillary lymph node dissection in breast cancer have a positive impact on chronic pain, sensory changes, and quality of life? Vishnoi, J.R.

175 S1 p. S29
article
85 Does the use of an Intraoperative device to assess margins reduce need for reexcison after breast conserving surgery: Multicentre Randomised Controlled Trial Bundred, N.

175 S1 p. S5
article
86 Early detection of breast cancer in high-risk women based on longitudinal changes in serum-based proteins: the TESTBREAST study Hagenaars, S.

175 S1 p. S1
article
87 Early integrated rehabilitation helps maintain good cognitive function in breast cancer patients – a comparison of self-reported cognitive function between the intervention group and control group in a prospective study in 511 patients Mavric, Z.

175 S1 p. S41-S42
article
88 Editorial Board
175 S1 p. ii
article
89 Effectiveness of a nurse-navigation intervention in vulnerable breast cancer patients – The Rebecca Study Bidstrup, P.E.

175 S1 p. S7
article
90 Effect of a 24 week home-based walking program on the incidence of aromatase inhibitor induced musculoskeletal pain: The WISE prospective, randomized, multicenter trial [SAKK 95/17] Honecker, F.

175 S1 p. S43-S44
article
91 Effect of Covid-19 pandemic on breast cancer disease progression Butt, A.

175 S1 p. S42
article
92 Effect of nodal status before and after neoadjuvant chemotherapy on prognosis in breast cancer: a Dutch population-based study De Wild, S.

175 S1 p. S12
article
93 Effect of socio-economic status and acculturation on breast cancer screening in Asian American women Stan, D.

175 S1 p. S29-S30
article
94 Efficacy and safety of the biosimilar QL1206 compared with denosumab in breast cancer with bone metastases: subgroup analyses of a phase III study Li, H.

175 S1 p. S68
article
95 Efficacy of pre-operative axillary ultrasonography in excluding nodal disease – can it replace sentinel lymph node biopsy in early stage breast cancer? Javed, N.

175 S1 p. S27
article
96 Epigenetic silencing of P16INK4a hasten disease stage in Carcinoma of Breast: A hospital-based study of North India Singh, S.

175 S1 p. S37
article
97 ERBB2 mRNA expression in HER2-low breast cancer Teng, X.

175 S1 p. S93
article
98 Evaluation and optimization of treatment for patients with metastatic breast cancer and receiving CDK4/6-inhibitors Henze, F.

175 S1 p. S34-S35
article
99 Evaluation of effect of post-biopsy mammogram on marker clip migration after Stereotactic-Guided Core Needle Breast Biopsy Baker, L.

175 S1 p. S30-S31
article
100 Evaluation of fertility preservation in young breast cancer patients Beketic Oreskovic, L.

175 S1 p. S53-S54
article
101 Evaluation of neoadjuvant chemotherapy response in breast cancer: radiological and pathological concordance Martínez Pairés, M.

175 S1 p. S65-S66
article
102 Evaluation of patient reported outcome measure following periareolar (Benelli) mammoplasty using BREAST-Q: Single centre 5-year experience Rapisarda, F.

175 S1 p. S20
article
103 Exosomes from mistletoe treated tumor cells for the stimulation of immune cells Sahay, J.

175 S1 p. S36
article
104 Exploring the impact of metastatic breast cancer support group in Nigeria Nwosu-Zitta, T.

175 S1 p. S74
article
105 Exploring the lymph node’s microenvironment for personalized management of luminal A breast cancer Gante, I.

175 S1 p. S81
article
106 Exploring timely perspectives of embodiment in women diagnosed with breast cancer undergoing oncoplastic breast surgery: A qualitative study from a plastic- and breast surgical outpatient clinic Thestrup Hansen, S.

175 S1 p. S53
article
107 External validation and clinical utility assessment of PREDICT v2.2 prognostic model in young, node-negative, systemic treatment-naïve breast cancer patients Wang, Y.

175 S1 p. S7-S8
article
108 Factors affecting Quality of Life among breast cancer survivors Fatima, A.

175 S1 p. S11
article
109 False-Negative Rates Between Pathological Lymph Node Status Between Ductal and Lobular Breast Cancer: A Retrospective Cohort Study of 83,152 Patients Oemrawsingh, A.

175 S1 p. S92
article
110 Ferromagnetic seed in breast surgery (lumpectomy and targeted axillary dissection (TAD)): our experience since 2018 Martínez Mateo, Y.A.

175 S1 p. S26
article
111 Finding patient-reported deterrents to adjunct Breast Cancer screening among patients with dense breast tissues. A cross sectional study in Pakistan Fatima, A.

175 S1 p. S43
article
112 First results on acute skin toxicity in model-based selected breast cancer patients treated with adjuvant intensity modulated proton therapy Sattler, M.G.A.

175 S1 p. S48
article
113 Fluorescence guided fully endoscopic axillary dissection for locally advanced breast cancer. A feasible novel technique York, E.

175 S1 p. S28
article
114 Forty-eight weeks of yogic intervention improves serum interleukins IL-10 and IL-1β along with fatigue and quality of life during the radiotherapy/chemotherapy in breast cancer patients: a randomized control study Mishra, A.

175 S1 p. S6
article
115 GC-MS based untargeted approach reveals metabolic perturbation in Tamoxifen resistant breast cancer cells Mishra, A.

175 S1 p. S75-S76
article
116 Gene expression profile at week 2 of neoadjuvant therapy course predicts outcome in HER2-positive breast cancer patients: an explorative analysis from NeoALTTO Di Cosimo, S.

175 S1 p. S78
article
117 Genome wide association study of long-term patient-reported outcomes following radiotherapy for breast cancer – results from the REQUITE cohort study Jandu, H.

175 S1 p. S38
article
118 Genomic signature to guide adjuvant chemotherapy treatment decisions for early breast cancer patients in France: a cost-effectiveness analysis Curtit, E.

175 S1 p. S59
article
119 Healthcare providers’ perceptions of the surgical treatment for male breast cancer: Time to add surgical options other than mastectomy to the discussion Levin Dagan, N.

175 S1 p. S22
article
120 HER2-low versus HER2-0 in Invasive Lobular Breast Carcinoma Fontes-Sousa, M.

175 S1 p. S86-S87
article
121 Home based care for terminal cancer patients: study from rural part of India Jana, S.

175 S1 p. S74
article
122 Home-monitoring of cancer-related fatigue in breast cancer patients Wijlens, K.A.E.

175 S1 p. S50-S51
article
123 How ‘breast aware’ are the Indian women? A study among the women visiting a tertiary-care, referral and teaching hospital Newton, M.V.

175 S1 p. S44
article
124 Imaging features of malignant lesions in women with PTEN Hamartoma Tumor Syndrome Hoxhaj, A.

175 S1 p. S88-S89
article
125 Imaging findings for response evaluation of ductal carcinoma in situ in breast cancer patients treated with neoadjuvant systemic therapy: a systematic review and meta-analysis Ploumen, R.

175 S1 p. S58-S59
article
126 Impact of axillary disease extent on baseline 18F-FDG PET/CT in clinically node-positive breast cancer patients on the accuracy of axillary surgical staging after NCT De Mooij, C.M.

175 S1 p. S15
article
127 Impact of biomarkers and other diseases on breast cancer risk and mortality: prospective cohort study in the UK Biobank Zhang, Y.

175 S1 p. S95
article
128 Impact of breast cancer diagnosis on women’s sexuality Bannour, R.

175 S1 p. S54
article
129 Impact of breast cancer treatment on women’s body image and self esteem Bannour, R.

175 S1 p. S54
article
130 Impact of lymphedema on health-related quality of life in early-stage breast cancer patients treated breast conserving therapy with or without sentinel lymph node biopsy: 2-year results from the randomized controlled trial BOOG2013–08 Wintraecken, V.

175 S1 p. S51
article
131 Impact of musical training in breast cancer patients with post-treatment cognitive, funtional and emotional sequelae Anchuelo, J.

175 S1 p. S56
article
132 Impact of pre-existing cardiometabolic diseases on cancer stage at diagnosis in the EPIC study Jansana, A.

175 S1 p. S9-S10
article
133 Impact of subcutaneous versus intravenous administration of pertuzumab and trastuzumab (PH) for the treatment of HER2-positive breast cancer in Montenegro Cicmil Saric, N.

175 S1 p. S72
article
134 Information needs of individuals from BRCA-harboring families: A systematic review and content analysis Park, S.Y.

175 S1 p. S37
article
135 Initial experience with targeted axillary dissection (TAD) guided by ultrasound in early-stage node positive breast cancer patients undergoing upfront surgery Siso, C.

175 S1 p. S25
article
136 Interhospital variations in diagnostic work-up following recall at biennial screening mammography – a population-based study Rozemond, F.

175 S1 p. S33
article
137 Interobserver variation in the assessment of HER2 low expression in breast cancer: can we improve by adjusting criteria? An international interobserver study Baez Navarro, X.

175 S1 p. S88
article
138 Intraoperative ultrasound is accurate for guiding breast conservative surgery in non-palpable ductal carcinoma in situ of the breast Esgueva, A.

175 S1 p. S4-S5
article
139 Intrinsic tumor subtype in hormone receptor (HR) positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer (ABC) treated with cyclin-dependent kinase 4/6 inhibitors (CDK 4/6i) and endocrine therapy (ET) – a retrospective analysis of real world data Martins, T.

175 S1 p. S68-S69
article
140 Investigating The Role of Several Inner Nuclear Membrane Proteins In Triple Negative Breast Cancer Rose, M.

175 S1 p. S78
article
141 Is sentinel lymph node biopsy without frozen section in early stage breast cancer sufficient in accordance with ACOSOG-Z0011? A retrospective review from King Chulalongkorn Memorial Hospital Treeratanapun, N.

175 S1 p. S21
article
142 Late cardiac effects in patients with left breast cancer treated with hypofractionated radiotherapy Yadav, B.

175 S1 p. S48
article
143 Levels of vitamin D and expression of the vitamin D receptor in relation to breast cancer risk and survival Huss, L.

175 S1 p. S83-S84
article
144 Living with the unknown: The experience of Cypriot individuals living with BRCA 1/2 mutations Christodoulidou, S.

175 S1 p. S75
article
145 Lobular carcinoma of the breast and response to targeted therapy with CDK4/6 inhibitors – a single Portuguese center experience Freitas, P.

175 S1 p. S73
article
146 Local recurrence of breast cancer after mastectomy. Impact of residual tissue in cancer follow-up Jimenez Gomez, M.

175 S1 p. S94-S95
article
147 Locoregional lymph node metastasis from occult breast cancer: Treatment options and prognosis in Denmark Nærum, A.W.

175 S1 p. S16
article
148 Long-term breast cancer risk after benign breast disease in population-based screening Roman, M.

175 S1 p. S6
article
149 Long-term yogic intervention improves the level of TNF-α, IFN-γ, MDA, and NO in breast cancer patients undergoing chemotherapy and/or radiotherapy: A randomized control study Jain, M.

175 S1 p. S35-S36
article
150 Magnetic delayed sentinel lymph node dissection in primary systemic therapy. Implications for enhanced axillary mapping (Update) Pantiora, E.

175 S1 p. S28
article
151 Mammographic breast density correlated with worse prognosis of early breast cancer regardless of menopausal status Lee, J.S.

175 S1 p. S93-S94
article
152 Margin status and Survival outcomes following breast conservation surgery: a metaanalysis Bundred, N.

175 S1 p. S24
article
153 Matching adjusted indirect comparison of PFS & OS comparing ribociclib + letrozole vs palbociclib + letrozole as first-line treatment of HR+/HER2− ABC: Analysis based on updated PFS & final OS results of MONALEESA-2 & PALOMA-2 Jhaveri, K.

175 S1 p. S2-S3
article
154 MaThAI: A MultiModal imaging combining Mammography and Thermalytix for better prioritization of mammography scans to detect early malignancies Kakileti, S.T.

175 S1 p. S34
article
155 Mesh-Pocket Supported Prepectoral Direct-to-Implant Breast Reconstruction: Preliminary Results of a Prospective Analysis Paepke, S.

175 S1 p. S13
article
156 MINIVAB trial: Minimally invasive breast cancer excision using vacuum assisted biopsy under ultrasound guidance Sanderink, W.

175 S1 p. S15
article
157 Morphometric analysis of ductal carcinoma in situ identifies features associated with low risk of progression to invasive breast cancer Leite, M.

175 S1 p. S90
article
158 Mutation detection rates associated with specific selection criteria for BRCA1/2 testing in 100 high risk families with breast cancer: A single center study Lee, J.S.

175 S1 p. S37
article
159 Neoadjuvant treatment for breast cancer patients in a Venezuelan breast center. Pathologic complete response: is it worth it? Acosta-Marin, V.

175 S1 p. S62-S63
article
160 Neratinib could be effective as monotherapy or in combination with Trastuzumab in HER2 low expressing breast cancer cells and organoid model Arshad, M.

175 S1 p. S77
article
161 Nipple-sparing mastectomy with primary breast reconstruction: Breast cancer local recurrence according to molecular subtype Golijanin, D.

175 S1 p. S26-S27
article
162 Non-Inflammatory skin involvement in Breast Cancer (T4b): Real-world Data from a Tertiary care centre in Eastern India Deepika, S.

175 S1 p. S72-S73
article
163 North East England outcomes in node positive breast cancer from the real world use of 21 gene recurrence score testing Gault, A.

175 S1 p. S66-S67
article
164 Novel breast cancer predisposing candidate genes identified in Brazilian families with hereditary breast cancer Bandeira, G.

175 S1 p. S39
article
165 Oesophagus exposure in hypofractionated breast cancer radiotherapy: an organ at risk commonly overlooked? Naimi, Z.

175 S1 p. S47
article
166 Oncologic outcome of Immediate Breast Reconstruction after mastectomy in breast cancer patients: A Systematic reviews and Meta-Analysis Kim, H.Y.

175 S1 p. S13
article
167 Oncophone20 study: Patients’ perception of telemedicine in the COVID-19 pandemic during follow-up visits for gynecological and breast cancers Picardo, E.

175 S1 p. S10
article
168 One-step nucleic acid amplification assay in palpable and non-palpable breast tumours Robalo Cordeiro, M.

175 S1 p. S81
article
169 Our early experience with Magseed and Savi-scout localization against wire localization Breast conserving surgery in impalpable breast cancer Tin, S.M.M.

175 S1 p. S69
article
170 Ovarian function suppression in early & locally advanced breast cancer: an audit of practice Roberts, N.

175 S1 p. S61-S62
article
171 Overview of patient preference sensitive attributes in eHealth interventions for breast cancer-related fatigue Beenhakker, L.

175 S1 p. S52
article
172 PAM50 genomic test in the management of early breast cancer – the importance of clinical-pathological data Valente, A.

175 S1 p. S77
article
173 Papillary carcinoma of breast – Clinicopathological characteristics, management, and survival Rehman, B.

175 S1 p. S23
article
174 Pathogenic mutations in ethnic Lebanese Arab patients with high risk for hereditary breast cancer Moukadem, H.

175 S1 p. S38
article
175 Pathologic complete response in triple negative breast cancer - A single Portuguese center experience Pina, A.

175 S1 p. S66
article
176 PATHways UK survey: Pathology perceptions on current biomarker testing and pathways for breast cancer in England Taniere, P.

175 S1 p. S90-S91
article
177 Patient-assisted versus standard compression in mammography screening: A randomized trial Louro, J.

175 S1 p. S32
article
178 Patterns and predictors of cancer-related fatigue domains after breast cancer: the influence of lifestyle Witteveen, A.

175 S1 p. S45
article
179 Peer Review Policy for the European Journal of Cancer (EJC)
175 S1 p. iii
article
180 Perceived injustice in cancer survivors: an exploration and a population-specific cut-off score Roose, E.

175 S1 p. S51-S52
article
181 Peripheral blood neutrophil/lymphocyte ratio as a prognostic factor in triple negative breast cancer Mendes, A.S.

175 S1 p. S32
article
182 Plasma L-arginine metabolic profiling in breast cancer patients reflects differences in cellular gene expression and metabolic activities according to subtype – A translational study in human breast cancer Hannemann, J.

175 S1 p. S83
article
183 Postoperative breast radiotherapy using deformable image registration of initial PET-CT before NAC Shiraishi, K.

175 S1 p. S49
article
184 Post-treatment quality of life among Sri Lankan women with breast cancer Seneviratne, S.

175 S1 p. S55
article
185 Predicting factors of local recurrence in ductal carcinoma in situ of the breast Pumarola Brussosa, C.

175 S1 p. S96
article
186 Prediction of axillary complete pathological response after neoadyuvant treatment in breast cancer cN1 patients Jimeno Fraile, J.

175 S1 p. S64-S65
article
187 Prediction of histological grade and molecular subtypes of invasive breast cancer using mammographic growth rate in screening Peters, J.

175 S1 p. S34
article
188 Predictive factors of macrometastasis in sentinel lymph node in invasive lobular carcinoma Julià, C.

175 S1 p. S18-S19
article
189 Preoperative MRI in women with newly diagnosed breast cancer: re-excision rates and additional findings Eriksson, J.

175 S1 p. S31-S32
article
190 Preoperative partial breast irradiation in low-risk breast cancer patients: a systematic review of literature Civil, Y.

175 S1 p. S46
article
191 Primary location of breast cancer and total tumor load of the sentinel lymph node David, D.

175 S1 p. S92
article
192 Primary results of ANZ 1002 : Post-operative Radiotherapy Omission in Selected Patients with Early breast Cancer Trial (PROSPECT) following pre-operative breast MRI Mann, B.

175 S1 p. S47
article
193 Prognostic impact of HER low expression in early breast cancer in a Tunisian center Rachdi, H.

175 S1 p. S82
article
194 PRO Hair Safe Study: The patient’s perspective on the effects of scalp cooling on hair preservation Brunner, C.

175 S1 p. S61
article
195 Prospective, Multi-Center, Artificial Intelligence Study for Early Prediction of Serious Events under Treatment Is Now Open for Recruitment in Breast Cancer - OMCAT Trial in Progress Tonk, C.H.

175 S1 p. S71-S72
article
196 Proton beam therapy for early breast cancer: a systematic review and quantitative synthesis of adverse clinical outcomes Holt, F.

175 S1 p. S46-S47
article
197 Psychosocial factors and the incidence of breast cancer: two-stage individual participant data meta-analyses Van Tuijl, L.

175 S1 p. S6-S7
article
198 Quality of life and lymphedema incidence after axillary surgery in pN1 breast cancer patients: lymphadenectomy vs. Sentinel lymph node biopsy Jimeno Fraile, J.

175 S1 p. S27-S28
article
199 Quality of life and patient satisfaction after nipple sparing mastectomy versus skin sparing mastectomy and immediate one stage versus two stages breast reconstruction Angelidou, E.

175 S1 p. S22
article
200 Quality of life in postmenopausal breast cancer patients with localized disease who finish endocrine treatment: a prospective study Arraras, J.I.

175 S1 p. S57
article
201 Quality of Life of breast cancer patients with COVID-19 disease Arraras, J.I.

175 S1 p. S62
article
202 Racial disparity and time to treatment initiation effects on survival differences in breast cancer: a DAGs-based review protocol for a systematic review of cohort studies Mokhtari Hesari, P.

175 S1 p. S74-S75
article
203 Radiotherapy in patients receiving anthracyclines: phase 3 SAFE trial (NCT2236806) interim analysis Visani, L.

175 S1 p. S48-S49
article
204 Randomised controlled trial of breast conserving therapy: 30 year analysis of the Scottish breast conservation trial Williams, L.

175 S1 p. S1-S2
article
205 Real world evidence from a Breast Screening pilot for the underprivileged: Experiences from Bruhat Bengaluru Mahanagara Palike hospitals Manjunath, G.

175 S1 p. S30
article
206 Real-world use of multigene signatures in early breast cancer: the experience by the Lombardy Genomic Assays for Breast Cancer Working Group Licata, L.

175 S1 p. S91
article
207 Residual Risk of Relapse: a Systematic Review and a Consensus Project on Unmet needs for HER2-positive non Metastatic Breast Cancer Patients Miglietta, F.

175 S1 p. S57-S58
article
208 Results from a large single institute experience of targeted intraoperative radiotherapy (TARGIT-IORT) as partial breast irradiation modality Vinante, L.

175 S1 p. S49
article
209 Retrospective thorough analysis of regional lymph node recurrence in breast cancer patients (REASON Trial) Liapi, A.

175 S1 p. S63
article
210 Risk factors of complications after nipple-sparing mastectomies in women with breast cancer risk gene mutations (BRCA1, BRCA2, PALB2) De La Torre-Fernandez De Vega, J.

175 S1 p. S43
article
211 Role of perioperative tranexamic acid in reducing drain volume in breast cancer patients undergoing axillary lymph node dissection: A randomized controlled trial Deepika, S.

175 S1 p. S19
article
212 Routine and interval detection of locoregional breast cancer recurrences and risk of subsequent distant metastasis: a population-based study Eijkelboom, A.

175 S1 p. S10
article
213 SAFE: A Microwave Imaging Device for Breast Cancer Early Screening Akduman, I.

175 S1 p. S32-S33
article
214 Screen-detected breast cancers have an improved 5-year recurrence free interval compared to interval and non-screened breast cancers: a population-based study de Munck, L.

175 S1 p. S31
article
215 Second primary cancer risks for female and male breast cancer survivors in England Allen, I.

175 S1 p. S11-S12
article
216 Selective pectoralis major muscle denervation in retro-pectoral implant based breast reconstruction reduces capsular contracture rate. Long-term single institution prospective case-control study Bernini, M.

175 S1 p. S23
article
217 Sentinel node mapping in patients with biopsy-proven metastatic axillary lymph nodes and upfront surgery: preliminary results of the Multimodal Targeted Axillary Surgery (MUTAS) trial Masó, P.

175 S1 p. S16
article
218 Serum methylmalonic acid concentrations at breast cancer diagnosis are not associated with distant metastases Wu, Q.

175 S1 p. S76-S77
article
219 Shared decision-making in breast cancer care: Evidence from a scoping literature review and a survey across breast units in Europe Oprea, N.

175 S1 p. S73-S74
article
220 Short-term surgical complications of skin-sparing mastectomy and direct-to-implant immediate breast reconstruction in women concurrently treated with adjuvant radiotherapy for breast cancer (2022; archives of plastic surgery (aps)) Kooijman, M.

175 S1 p. S20-S21
article
221 Single nucleotide polymorphisms of ABCB1 (rs1128503) and ABCC2 (rs145008610) genes and its clinical impact in ER & PR positive breast cancer patients in a tertiary care hospital of India Mistry, T.

175 S1 p. S79
article
222 Sonographic assessment of the axilla in breast cancer: changing the threshold James, S.

175 S1 p. S89
article
223 Spatial Immunophenotyping Identifies Differential Infiltration of Immunosuppressive Subsets in Tumor Stroma and Invasive Margin and PDL1 expression in Inflammatory and non-Inflammatory Breast Cancer Patients overexpressing X-Linked Inhibitor of Apoptosis Protein Van Berckelaer, C.

175 S1 p. S87
article
224 SPECT/CT lymphoscintigraphy can accurately localize the sentinel lymph nodes and the clipped node in breast cancer patients undergoing targeted axillary dissection after neoadjuvant chemotherapy Dilege, E.

175 S1 p. S17
article
225 Superior survival after breast conserving therapy versus mastectomy – a multicenter Asian cohort study of 3655 patients Leong, F.

175 S1 p. S18
article
226 Surgical choices and complications in elderly women: a single center retrospective analysis in frail vs non frail breast cancer patients Costa, P.

175 S1 p. S84
article
227 Surgical outcomes after neoadjuvant systemic therapy in patients with lobular carcinoma Van Hemert, A.

175 S1 p. S17
article
228 Systemic therapies post progression on CDK4/6 inhibitors in patients with oestrogen receptor positive metastatic breast cancer: Real world data from Guy’s Cancer Centre Gousis, C.

175 S1 p. S65
article
229 Targeted axillary dissection or sentinel node biopsy after neo-adjuvant treatment in clinically node positive patients – the West of Scotland experience Romics, L.

175 S1 p. S17-S18
article
230 The combination of platelet-to-lymphocyte ratios with TIL assessment as prognostic factor for patients with triple negative breast cancer Horimoto, Y.

175 S1 p. S86
article
231 The development of an interactive online referral tool for breast services in Wales: optimising the patient referral pathway Gohobur, S.

175 S1 p. S90
article
232 The effectiveness of personalised surveillance and aftercare in breast cancer follow-up: a systematic review van Maaren, M.

175 S1 p. S11
article
233 The effect of behavioral graded activity on physical activity level, health-related quality of life, and symptom management in cancer patients and survivors: systematic review and meta-analysis Lahousse, A.

175 S1 p. S9
article
234 The effect of intra-operative margin assessment during breast conserving surgery for breast cancer in a Dutch cohort Wooldrik, S.

175 S1 p. S25
article
235 The effect of prehabilitation in cancer patients: systematic review and meta-analysis Lahousse, A.

175 S1 p. S40
article
236 The impact of therapeutic drug monitoring-based tamoxifen dose-reductions on endocrine side effects in patients with primary breast cancer Buijs, S.

175 S1 p. S58
article
237 The Impact on Management and Outcomes of Benign and High-Risk Breast Lesions After the Introduction of Vacuum Assisted Excision Wooldrik, S.

175 S1 p. S26
article
238 The mediating effect of pain catastrophizing and perceived injustice in the relationship of pain on health-related quality of life in breast cancer survivors Roose, E.

175 S1 p. S54
article
239 The mediating effect of perceived injustice and pain catastrophizing in the relationship of pain on fatigue and sleep in breast cancer survivors: a cross-sectional study Lahousse, A.

175 S1 p. S50
article
240 The place of videos illustrating the techniques of breast surgery in the procedural training of residents in gynecology Bannour, B.

175 S1 p. S25
article
241 The positive predictive value of breast lesions of uncertain malignant potential, their correlation with radiologic findings and their follow-up on a large single-institution series Bernini, M.

175 S1 p. S24-S25
article
242 The psycho-emotional condition of the spouses of breast cancer patients Georgiou, A.

175 S1 p. S36-S37
article
243 The relationship among bowel FDG-PET uptake, pathological complete response, and eating habits in breast cancer patients undergoing neoadjuvant chemotherapy Tiberio, P.

175 S1 p. S63-S64
article
244 The role of axillary staging in patients with Ductal Carcinoma In Situ (DCIS) on diagnostic tissue biopsy Jain, U.

175 S1 p. S28-S29
article
245 The successful patient-preference design for the LORD-trial to test whether active surveillance for low-risk Ductal Carcinoma In Situ is safe Schmitz, R.

175 S1 p. S3-S4
article
246 The utility of virtual clinics in the assessment of patients with mastalgia: a model for breast services post-pandemic? Regan, A.

175 S1 p. S89
article
247 The value of palpation, US and NMR in staging of axilla in patients with breast cancer in order to avoid unnecessary ALND Maksimovic, Z.

175 S1 p. S23-S24
article
248 Time to surgery after completion of neoadjuvant chemotherapy does not negatively impact recurrence and survival outcomes in breast cancer patients Bek, S.

175 S1 p. S27
article
249 Title Page
175 S1 p. i
article
250 Trained Artificial Intelligence (AI) for Predicting Therapy Discontinuation Based on Patient Observations in Advanced Breast Cancer Kates, R.E.

175 S1 p. S72
article
251 Triple negative breast cancers: Rising menace in the developing world and treatment challenges Patel, S.

175 S1 p. S93
article
252 Tumor-Infiltrating lymphocytes and its relationship with survival in a series of primary breast cancer patients according to the different surrogated molecular subtypes Falo Zamora, C.

175 S1 p. S96
article
253 Tumour characteristics and radiological response are better predictors than tumour extent of axillary pathological complete response after neoadjuvant systemic therapy Du De Xuan, S.

175 S1 p. S18
article
254 Ultrahypofractionated radiation therapy for breast cancer: two-year normal tissue effects Oulkadi, R.

175 S1 p. S46
article
255 Ultrasound measurement of the distance between the breast tumor and the skin: a cut-off value for safe skin preservation. Diagnostic accuracy study Brandão, R.

175 S1 p. S22
article
256 Underestimated risk of involved margins in Skin (SMM)- and Nipple Sparing Mastectomies (NSM) – Data and Multimodal Approach for Improvement Paepke, S.

175 S1 p. S13-S14
article
257 Unusual ocular manifestations of breast carcinoma: A single institute case series in the Indian population Murali-Nanavati, S.

175 S1 p. S69
article
258 Update of the European Breast Cancer Guidelines for Screening and Diagnosis: priority questions and new topics Morgano, G.P.

175 S1 p. S31
article
259 Usability test of BREAST-Q questionnaires during pre-implementation of Patient-Reported Outcomes Measures in a Plastic- and Breast Surgical Outpatient Clinic Prüsse, J.

175 S1 p. S80-S81
article
260 Use of Arista™ AH Absorbable Hemostat in breast surgery – analysis of seroma volumes and duration of drainage Klein, E.

175 S1 p. S14
article
261 Use of frailty measurements in observational studies on older patients with breast cancer: A systematic review Sanchez, D.

175 S1 p. S94
article
262 Use of immersive virtual reality for management of anxiety and depression among chemotherapy-naïve Filipino breast cancer outpatients in a national university hospital Ando, M.

175 S1 p. S35
article
263 Utility Of Telephone-Based Psychological Support Among Breast Cancer Patients During Covid-19 Pandemic: An Observational Study Datta, A.

175 S1 p. S74
article
264 Validation Sentinel Lymph Node Biopsy Study in post NACT cN0 Axilla using low-cost dual dye technique: Potential Solution for Resource Poor Settings Chavda, J.

175 S1 p. S20
article
265 What are women’s perceptions of diagnostic DBT and targeted breast ultrasound for the evaluation of their focal breast complaints? Siebers, C.

175 S1 p. S92-S93
article
266 Who is at risk of developing breast cancer-related fatigue – a prediction study Beenhakker, L.

175 S1 p. S52-S53
article
                             266 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands